Patients exposed to a higher dose may be subject to bleeding complications. Apotex Corp announced the voluntary recall of 2 batches of Enoxaparin Sodium Injection ...
Syringe marking errors, which can lead to incorrect dosing, caused a recall of Enoxaparin Sodium Injection, a generic version of blood clot medication Lovenox. The recall issued Tuesday by Apotex, a ...
LANGHORNE, Pa.--(BUSINESS WIRE)--#Enoxaparin--Techdow USA Inc. (“Techdow USA”), a growing market leader and vertically integrated generic injectables company, today announced the launch of its 30mg, ...
(RTTNews) - Sandoz, Inc., an unit of Novartis Pharma AG, is recalling one lot of deep vein thrombosis (DVT) medication Enoxaparin Sodium in the form of injection for the potential exposure to high ...
The U.S. Food and Drug Administration today approved the first generic version of Lovenox (enoxaparin sodium injection), an anti-coagulant drug used to prevent deep vein thrombosis (DVT), a ...
“We are very excited to bring our enoxaparin biosimilars Inclunox ® and Inclunox ® HP to market by building on our worldwide experience with biosimilars. The enoxaparin biosimilar market represents ...
Please provide your email address to receive an email when new articles are posted on . Techdow USA announced the FDA approval of its generic enoxaparin sodium for marketing in the U.S. The ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback